Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS)-Reference-Cited by-同舟云学术

Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS)

Published:2015-06-24 Issue:4 Volume:21 Page:469-476
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Langley A. R.¹,Stain A. M.¹,Chan A.²,McLimont M.¹,Chait S.¹,Wu J.³,Poon M.-C.⁴,Card R.⁵,Israels S. J.⁶,Laferriere N.⁷,Klaassen R. J.⁸,Rivard G. E.⁹,Cloutier S.¹⁰,Hawes S.¹¹,Feldman B.¹²,Blanchette V.¹

Affiliation:

1. Division of Hematology/Oncology; The Hospital for Sick Children; Toronto ON

2. Department of Pediatrics; McMaster University; Hamilton Health Sciences Foundation Pediatric Thrombosis and Hemostasis; McMaster Children's Hospital; Hamilton ON Canada

3. Division of Hematology/Oncology/BMT; Department of Pediatrics; UBC & BC Children's Hospital; Vancouver BC Canada

4. Departments of Medicine, Pediatrics and Oncology; University of Calgary and Southern Alberta Rare Blood and Bleeding Disorders Comprehensive Care Program; Foothills Hospital; Alberta Health Services; Calgary AB Canada

5. Saskatchewan Bleeding Disorders Program; Royal University Hospital; Saskatoon SK Canada

6. Department of Pediatrics and Child Health; University of Manitoba; Winnipeg MB Canada

7. Division of Hematology/Oncology; Thunder Bay Regional Cancer Care; Thunder Bay ON

8. Department of Pediatrics; University of Ottawa; Children's Hospital of Eastern Ontario; Ottawa ON Canada

9. Division of Hematology/Oncology; Department of Pediatrics; CHU Sainte-Justine; Montreal QC Canada

10. Centre de l'hémophilie de l'est du Québec de Québec-Hôpital de l'Enfant-Jésus; Université Laval; Québec QC Canada

11. Division of Hematology/Oncology; IWK Hospital; Halifax NS

12. Division of Rheumatology; The Hospital for Sick Children; Toronto ON

Funder

Canadian Blood Services

Héma Quebec Partnership Fund

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12713/fullpdf

Reference38 articles.

1. Haemophilia A: from mutation analysis to new therapies;Graw;Nat Rev Genet,2005

2. Evatt B Economic Issues and Program Development for Hemophilia 2002

3. The economics of haemophilia prophylaxis: governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium;Feldman;Haemophilia,2007

4. Economics of prophylactic treatment;Schramm;Haemophilia,2003

5. Social participation of patients with hemophilia in the Netherlands;Plug;Blood,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Application of peripherally inserted central catheter in immune tolerance induction treatment of children with hemophilia A and accompanying inhibitors in China;Hematology;2023-09-07

3. Between Scylla and Charybdis: thrombosis in children with hemophilia;Frontiers in Pediatrics;2023-05-23

4. Comparison of perioperative practices for placement of central venous access devices (CVAD) in children with haemophilia;The Journal of Haemophilia Practice;2022-01-01

5. Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A;The Journal of Pediatrics;2021-07